Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Shareholder Equity 2017–2025
Aquestive Therapeutics Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aquestive Therapeutics Inc. shareholder equity as of December 31, 2025: -33.7M, a 44.04% decrease year-over-year.
- Aquestive Therapeutics Inc. shareholder equity for 2025 were -33.7M, a 44.04% decrease from 2024.
- Aquestive Therapeutics Inc. shareholder equity for 2024 were -60.2M, a 43.51% decrease from 2023.
- Aquestive Therapeutics Inc. shareholder equity for 2023 were -106.5M, a 10.18% decrease from 2022.
- Aquestive Therapeutics Inc. shareholder equity for 2022 were -118.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aquestive Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-34 |
| 2024 | $-60 |
| 2023 | $-106 |
| 2022 | $-119 |
| 2021 | $-82 |
| 2020 | $-48 |
| 2019 | $-6 |
| 2018 | $10 |
| 2017 | $-26 |
Aquestive Therapeutics Inc. Shareholder Equity — FAQ
Aquestive Therapeutics Inc. (AQST) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's shareholder equity history?
The chart and table above show Aquestive Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.